Cost-Effectiveness Analysis of a Mobile-Based Intervention for Patients with Type 2 Diabetes Mellitus

Table 1

Cost comparison between the mHealth group and usual care group at 12-month follow-up (CNY¥).

	n	Registration fee	Material fee	Treatment fee	Western medicine fee	Laboratory fee	Chinese patent drug fee	Hospitalization expenses	Total patient Cost
		Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)
Usual care group	85	355.04	302.01	18.88	7491.68	507.51	716.65	3036.29	12428.06
		(322.30)	(325.71)	(18.91)	(6922.83)	(501.28)	(719.88)	(5784.70)	(11122.32)
mHealth group	130	379.87	128.61	157.55	5099.62	811.79	225.24	951.35	7754.03
		(282.30)	(203.79)	(103.28)	(4832.08)	(395.51)	(634.72)	(2955.21)	(7118.53)
T		−0.596	4.380	−14.931	2.774	−4.718	5.124	3.071	3.441
P		0.552	<0.001	<0.001	0.006	<0.001	<0.001	0.003	0.001
Usual care-HbA1c uncontrol	45	377.11	348.83	18.89	7945.19	532.71	696.72	3045.30	12964.75
		(340.78)	(360.50)	(18.28)	(7255.01)	(539.55)	(634.65)	(6200.01)	(11620.74)
Usual care-HbA1c control	40	340.78	249.34	18.87	6981.48	479.15	739.08	3026.16	11824.27
		(302.54)	(276.59)	(19.82)	(6583.05)	(459.59)	(812.89)	(5357.71)	(10648.13)
t		0.668	1.414	0.005	0.638	0.489	−0.269	0.015	0.470
P		0.506	0.161	0.996	0.525	0.626	0.788	0.988	0.640
mHealth-HbA1c uncontrol	33	429.52	173.77	129.32	6347.86	747.45	278.60	2098.85	10205.37
		(351.12)	(225.54)	(112.33)	(6369.31)	(402.88)	(600.78)	(4472.55)	(9488.17)
mHealth-HbA1c control	97	362.97	113.25	167.15	4674.96	833.68	207.09	560.96	6920.07
		(254.67)	(194.70)	(98.79)	(4139.41)	(392.67)	(647.86)	(2112.06)	(5942.70)
t		1.171	1.480	−1.834	1.411	−1.069	0.558	1.904	1.868
P		0.244	0.141	0.069	0.166	0.290	0.578	0.065	0.069